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Abstract
Background: The occurrence of diabetes has greatly increased in low- and middle-income countries, particularly in Asia, as
has the prevalence of overweight and obesity; in European-derived populations, overweight and obesity are established
causes of diabetes. The shape of the association of overweight and obesity with diabetes risk and its overall impact have not
been adequately studied in Asia.
Methods and Findings: A pooled cross-sectional analysis was conducted to evaluate the association between baseline
body mass index (BMI, measured as weight in kg divided by the square of height in m) and self-reported diabetes status in
over 900,000 individuals recruited in 18 cohorts from Bangladesh, China, India, Japan, Korea, Singapore and Taiwan. Logistic
regression models were fitted to calculate cohort-specific odds ratios (OR) of diabetes for categories of increasing BMI, after
adjustment for potential confounding factors. OR were pooled across cohorts using a random-effects meta-analysis. The
sex- and age-adjusted prevalence of diabetes was 4.3% in the overall population, ranging from 0.5% to 8.2% across
participating cohorts. Using the category 22.5–24.9 Kg/m
2 as reference, the OR for diabetes spanned from 0.58 (95%
confidence interval [CI] 0.31, 0.76) for BMI lower than 15.0 kg/m
2 to 2.23 (95% CI 1.86, 2.67) for BMI higher than 34.9 kg/m
2.
The positive association between BMI and diabetes prevalence was present in all cohorts and in all subgroups of the study
population, although the association was stronger in individuals below age 50 at baseline (p-value of interaction,0.001), in
cohorts from India and Bangladesh (p,0.001), in individuals with low education (p-value 0.02), and in smokers (p-value
0.03); no differences were observed by gender, urban residence, or alcohol drinking.
Conclusions: This study estimated the shape and the strength of the association between BMI and prevalence of diabetes in
Asian populations and identified patterns of the association by age, country, and other risk factors for diabetes.
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Introduction
The prevalence of diabetes has increased in the last decades in
many low- and middle-income countries (LMIC) [1] and this trend,
which is almost completely accounted for by type 2 diabetes, is
expected to continue [2]. The current estimated age-adjusted
prevalence of diabetes in China (4.2%) is expected to increase by
1.9% to 5.0% in2030[3].However,results froma survey conducted
in 2007-08 in China reported a higher prevalence (9.7%, including
previously undiagnosed diabetes) [4]. A similar increase is expected
inIndia (from 7.8%in2010to9.3%in2030)andinhigh-prevalence
countries such as Malaysia (from 11.6% in 2010 to 13.8% in 2030)
[3]. Southern and Eastern Asian countries account for half the
deathsattributabletodiabetesworldwide[1,5]andtheconsequences
of a rising incidence and prevalence of diabetes and other chronic
diseases will be particularly important, both locally and globally [5].
A concurrent increase in the prevalence of overweight and obesity
over the same time period has been observed in many Asian
countries [6]. In rural China, the prevalence of overweight has
increased from 5.3% in men and 9.8% in women in 1992 [7] to
13.6% in men and 14.4% in women in 2002 [8]. Corresponding
figures for obesity were 0.5% (men) and 0.7% (women) in 1992 and
1.8% (men) and 3.0% (women) in 2002. This trend has profound
implicationsfortheexpectednumberofdiabetespatientswhowillbe
diagnosed in this region in future decades.
Lifestyle risk factors for type 2 diabetes include increased body
weight, weight gain, and lack of physical activity [9]. A causal
association with tobacco smoking is suspected [10]. Roles for
specific foods such as fruits, vegetables and low-fat dairy, and
nutrients, including unsaturated fat and fibre, in reducing diabetes
risk, are suspected but not established [11]. Increased body mass is
one of best investigated risk factors for the disease, but the
evidence comes primarily from studies conducted in populations of
European origin. With few exceptions [12–14], studies on the
relation between body mass and risk of type 2 diabetes in Asia
have been conducted among convenience, small-scale samples.
The proportion of healthy adults with a body mass lower than
20 kg/m
2 is larger in Asia than in high-income countries; the
greater population variation in Asians may offer an opportunity to
better characterize the role of BMI in determining diabetes risk.
The Asia Cohort Consortium (ACC) is a collaboration of
longitudinal studies aimed at sharing resources to investigate the
distribution and determinants of chronic diseases across the
continent [15]. The Consortium provided the opportunity to study
the relation between BMI and prevalence of diabetes in a large
population across several countries of South and East Asia.
Materials and Methods
Ethics Statement
This study was approved by the Institutional Review Board of
the Fred Hutchinson Cancer Research Center. Informed consent
was obtained by individual studies.
Study Population and Data Collection
The cohorts included in this project were identified through a
systematic literature search, followed by a survey that was sent to
the investigators of each cohort to further determine study
eligibility. Eighteen cohorts were included in the pooling project.
Approval has been obtained from relevant ethics committees.
All participating cohorts were required to have data on diabetes at
baseline (self-reported), BMI at baseline (measured or self-reported),
age, and sex. Additional data were available from selected cohorts on
tobacco smoking (18 cohorts), alcohol drinking (14 cohorts), education
(10 cohorts), and urban/rural residence (18 cohorts). Data on waist
measurement were available only from a small subset of the whole
study population and were not used in the analysis. Information on
type of diabetes and age at diagnosis was not available.
Individual data from participating cohorts were harmonized and
analyzed at the ACC coordinating center at the Fred Hutchinson
Cancer Research Center. This harmonization process involved several
rounds of discussions with each cohort to ensure that variables had
been correctly interpreted and extracted. Cohort-specific analyses were
distributed to each cohort’s data management team for review to
ensure that the results were in line with the cohort’s own analyses.
Repeated measurements of BMI during follow-up were available
from fivecohorts, for a total of 121,732 individuals, of whom 37,399
had one repeated measurement, 72,531 two repeated measure-
ments and 11,802 three. The yearly change in mean BMI was
compared between diabetic and non-diabetic individuals.
Statistical Analysis
After exclusion of subjects with missing data on diabetes
(n=79,414), age (n=2), or BMI (n=11,696), 934,154 subjects
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prevalence of diabetes was adjusted by age and sex using direct
standardization, based on the sex and age distribution of the whole
study population. The association between diabetes and BMI was
examined in logistic regression models employing a categorical
representation of BMI as the independent variable. Ten BMI
levels were established: ,15.0, 15.0–17.4, 17.5–19.9, 20.0–22.4,
22.5–24.9, 25.0–27.4, 27.5–29.9, 30.0–32.4, 32.5–34.9, and
$35.0 kg/m
2. The categories were chosen to increase our ability
to investigate the association between BMI and diabetes, in
particular at the extremes of the BMI distribution. We used the
standard cut-points for underweight, overweight and obesity
rather than those proposed by the World Health Organization
for Asian populations [16] to enable direct comparisons with
studies conducted in other populations. However, we conducted
additional analyses using the ‘Asian’ cut-points (,18.5, 18.5–22.9,
23.0–24.9, 25.0–29.9, $30.0). Using the BMI range 22.5–
25.0 kg/m
2 as the reference category (23.0–24.9 in the analysis
with ‘Asian’ cut-points), odds ratios (OR) and 95% confidence
intervals (CI) were estimated for the other BMI categories, after
adjusting for probable confounders, including baseline age ( ,40,
40–49, 50–59, 60–69, 70–79, and $80) and sex. Additional
variables were adjusted for in some analyses, namely tobacco
smoking (ever/never), alcohol drinking (ever/never), education
(low [less than secondary school]; medium [secondary school];
high [more than secondary school]), and area of residence (urban
or suburban; rural).
In analyses presented here, the association between BMI and
diabetes prevalence was estimated separately for each cohort. We
assumed that the cohort-specific log OR for BMI has a fixed-effect
component that is common to all cohorts and a random effect that
is cohort-specific. The random effects for the log OR were
assumed to be normally distributed, with mean zero; that is, we
assumed that ^ b bij, the estimated log OR for the j-th BMI level in
the i-th cohort, has distribution ^ b bij*N(bj,^ s s2
ijzt2
j ) where ^ s s2
ij is the
within-study variance of ^ b bij as estimated from the logistic
regression model [17,18]. Parameters bj and 95% confidence
intervals were estimated in the meta-analysis. The random effects
model employs a weighting scheme based on the inverse of the
variance; in general, weights are closely approximated by cohort
size, but also depend on the between cohort variance. Linear trends
were analyzed by fitting logistic regression models including BMI as
a continuous variable: in these analyses, the unit of exposure is one
kg/m
2. Logistic regression analysis was performed using the
GENMOD procedure in SAS version 9.2 [19]. The meta-analysis
was performed using the SAS MIXED procedure [19].
In order to explore possible heterogeneity by Asian ethnicity and
economic development, analyses were conducted agglomerating
cohorts into three regions: (i) India and Bangladesh; (ii) China,
Taiwan, Korea, and Singapore; (iii) Japan. Additional stratified
analyseswere alsoperformed bysex,agegroups,education,tobacco
smoking, and alcohol drinking. In stratified analyses, a cohort- and
stratum-specific logistic regression model was fit with BMI
categories as a predictor. For each BMI level, effects of the
stratification factor were examined in a meta-analysis regressing log
OR (relative to the BMI reference level) against the stratification
factor entered as a fixed effect while allowing for cohort random
effects. Stratum-specific least squares mean values of the log OR are
reported. Assumptions about stratum-specific differential change in
diabetes prevalence acrosstheentireBMIrange wereexamined ina
meta-analysis ofBMIeffectestimates whereBMIhadbeen included
in the first stage as a continuous linear predictor. More highly
stratified analyses in which differential effects of sex, age, and
smoking status acrossthe three Asian subgroups wereexamined in a
similar manner, but with the addition of tests of the interaction
between subgroup by stratification variable obtained in the meta-
analysis. In sensitivity analyses, we have excluded three cohorts
which were established in the 1980s.
Results
Table 1 shows the key characteristics of cohorts included in the
analysis. The size of the studies ranged from 5,000 individuals in
one study from Taiwan to about 150,000 in one study from China.
Enrolment in the studies ranged from the mid-1980s (one study
from China and two from Japan - these cohorts were excluded in a
sensitivity analysis) to the early 2000’s (studies from Bangladesh,
Korea and one from China): the majority of subjects were enrolled
in the 1990s. The average age at baseline was 54.5 years (standard
deviation [sd] 10.4; range of cohort-specific averages 37.1-60.5).
Nine of the cohorts had self-reported information on BMI, while
height and weight were measured in the other nine cohorts; the
average BMI was 23.5 kg/m
2 (sd 3.5; range 19.8 – 24.0). Overall,
39,794 cohort members (adjusted prevalence 4.3%) reported
diabetes at baseline: the age- and sex-adjusted prevalence was
lowest in one study from China (0.5%) and highest in the study
from Singapore (8.2%). Table 1 also reports information on cohort
members with missing information on diabetes: the proportion of
members with missing information was above 10% in three
cohorts, between 1 and 10% in three additional cohorts, and
below 1% in the remaining 12 cohorts. With the exception of the
cohort from India, subjects with missing information were older
than subjects with valid information; the mean BMI, however, was
similar in subjects with and without missing information.
There was a six-fold difference in the age- and sex-adjusted
prevalence of diabetes between the category with highest BMI
(35.0 kg/m
2 or higher; prevalence 8.6%) and that with the lowest
BMI (less than 15 kg/m
2; prevalence 1.3%). The prevalence OR
for diabetes in relation to BMI categories ranged from 0.58 (95%
CI 0.31, 0.76) to 2.23 (95% CI 1.86, 2.67) (Table 2). The
prevalence of diabetes increased linearly across the range of BMI
categories, with an overall coefficient equal to 0.084/Kg/m
2 (i.e.,
the OR of diabetes for an increase in one Kg/m
2 BMI was 1.088).
The cohort-specific coefficients ranged from 0.036 to 0.200.
Adjustment for additional covariates, including education, urban
residence, and tobacco smoking, did not alter the results presented
in Table 2 (not reported in detail).
Women reported a lower prevalence of diabetes than men (age-
adjusted prevalence, 3.7% vs. 4.8%, p-value ,0.0001), but the
shape of the association between BMI and prevalence of diabetes
was consistent between the sexes (p-value for interaction 0.8). The
prevalence of diabetes strongly increased with age (sex-adjusted
prevalence 1.9% below age 50, 4.4% in the age group 50–59, and
6.8% at age 60 or above); although, in the low-BMI range, the OR
for diabetes were comparable in these three age groups, the
association between high BMI and diabetes prevalence was
stronger in younger than in older individuals (p-value for
interaction ,0.0001). Specifically, ORs in the categories 27.5–
29.9, 30.0–32.4, 32.5–35.0 and more than 35.0 kg/m
2 were 1.90,
2.77, 3.44 and 3.95 below age 50, 1.42, 1.76, 2.29 and 2.76 in the
age group 50–59, and 1.32, 1.39, 1.68, 1.79 at age 60 and above.
Figure 1 shows the age- and sex-adjusted prevalence of diabetes
in categories of BMI in the three geographic regions (Japan;
China, Taiwan, Korea, and Singapore; India and Bangladesh),
and Figures 2A and 2B show the corresponding ORs for men and
women, respectively. The prevalence of diabetes was consistently
lower in India and Bangladesh than in the other countries
(Figure 1). Compared with China, Taiwan, Korea, and Singapore,
BMI and Diabetes in Asia
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lower than 22.5 kg/m
2; in individuals with higher body mass,
however, the prevalence of diabetes in the two regions was similar
(Figure 1).
Among both men and women, the apparent protection exerted
by low body mass (below 22.5 kg/m
2) on diabetes prevalence was
more pronounced in India and Bangladesh than in the other
countries included in the study (Figures 2A and 2B). In China,
Taiwan, Korea, and Singapore this effect was nonetheless stronger
than in Japan. Conversely, for high BMI (above 25 kg/m
2), no
clear differences emerged among the country-specific results. A
similar pattern was seen from the separate analysis of each
individual cohort, although the numbers of cases of diabetes
included in some categories were rather small, thus limiting the
precision of the results (Table S1).
Figure 3 shows the results stratified by area of residence,
education, tobacco smoking, and alcohol drinking. The association
between BMI and prevalence of diabetes was suggested to be
stronger in rural than in urban/suburban populations, though the
rural population had a much lower diabetes prevalence in every
BMI group (p-value for interaction 0.3; Figure 3A). The
relationship was also stronger in subjects with less than the highest
education than in subjects with high education (p-value for
interaction 0.02; Figure 3B). Because the prevalence of tobacco
smoking and alcohol drinking was low in women, the stratified
analyses by these factors was restricted to men: the association
between BMI and prevalence of diabetes was stronger in smokers
than non-smokers (p-value 0.03; Figure 3C), no difference was
observed between drinkers and non-drinkers (p-value 0.2;
Figure 3D).
In all five cohorts with repeated BMI measurements during
follow-up, individuals with diabetes experienced a decrease in BMI
over time (cohort-specific mean change ranging from 20.06 to
20.2 kg/m
2 yr), whereas in four of the five cohorts, the mean BMI
Table 1. Characteristics of the cohorts included in the pooled analysis.
Cohort members with non-missing information on diabetes Diabetes missing
No of Period of Age at Diabetes at Urban % No of
Cohort Ref* subjects
a enrolment baseline
b BMI
b baseline (%)
c (%) males subjects
a Percent
Japan
3 Pref Aichi [a1] 22,641 1985 54.6 22.1 (2.9) 4.8 100.0 47.2 10,405 46.0
Ibaraki [a2] 97,608 1993–1994 58.8 23.5 (3.2)
d 2.5 100.0 31.2 0 0.0
JACC [a3] 75,486 1988–1990 57.0 22.8 (3.3) 4.9 100.0 42.0 11,196 14.8
JPHC1 [a4] 42,771 1990 49.6 23.6 (3.0) 2.5 100.0 47.8 0 0.0
JPHC2 [a4] 55,712 1993–1994 54.2 23.5 (3.1) 4.9 100.0 47.2 0 0.0
3 Pref Miyagi [a1] 29,554 1984 56.9 23.3 (3.4) 5.5 54.4 45.0 0 0.0
Miyagi [a5] 44,868 1990 52.0 23.6 (3.0) 3.9 100.0 47.9 0 0.0
Ohsaki [a6] 47,710 1995 60.1 23.5 (3.3) 5.3 100.0 48.2 0 0.0
China
CHEFS [a7] 143,884 1990–1992 55.2 22.6 (3.7)
d 2.1 59.4 49.2 10,907 7.6
SCS
e [a8] 18,100 1986–1989 55.3 22.2 (3.0) 0.5 100.0 100.0 0 0.0
SMHS
e [a9] 61,379 2001–2006 54.9 23.7 (3.1)
d 3.0 100.0 100.0 0 0.0
SWHS
f [a10] 74,881 1996–2000 52.1 24.0 (3.4)
d 2.7 100.0 0.0 0 0.0
Taiwan
CBCSP [a11] 23,703 1991–1992 47.3 24.0 (3.4)
d 3.1 64.6 50.3 65 0.3
CVDFACTS [a12] 5,128 1990–1993 47.0 23.7 (3.5)
d 5.0 100.0 44.1 3 0.1
Korea
KMCC [a13] 15,058 1993–2004 55.5 23.6 (3.2)
d 4.7 58.4 39.8 955 6.3
Singapore
SCHS [a14] 63,257 1993–1998 56.5 23.1 (3.3) 8.2 100.0 44.2 0 0.0
Bangladesh
HEALS [a15] 11,149 2000–2002 37.0 19.8 (3.2)
d 5.3 0.0 42.5 321 2,9
India
MCS [a16] 101,265 1991–1997 51.8 22.2 (4.1)
d 2.5 100.0 68.3 45,562 45.0
Total 934,154 1984–2006 54.5 23.1 (3.5) 4.3 89.5 48.5 79,414 8.5
*See Reference List S1
aMinor differences in the number of subjects compared to the original publications are explained by selection criteria in the different analyses
bMean (SD) for BMI and mean for age at baseline.
cPrevalence of diabetes is standardized for age and sex.
dBMI was estimated using weight and height measured at enrollment. For other studies weight and height were self-reported.
eCohort restricted to men.
fCohort restricted to women.
doi:10.1371/journal.pone.0019930.t001
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+0.3 kg/m
2 yr; in the fifth cohort the mean BMI decreased by -
0.02 kg/m
2 yr). In all cohorts, the difference in BMI change
between diabetic and non-diabetic individuals was statistically
significant.
The summary results of the analysis based on ‘Asian’ cut-points
are reported in Table S2. The results of the sensitivity analysis
excluding the cohorts enrolled in the 1980s are reported in Table
S3. They were similar to the results based on all cohorts.
Discussion
This analysis of more than 900,000 adults from seven Asian
countries confirmed the strong relationship between increased
body mass and prevalence of diabetes; this has been observed in
other populations, mainly in high-income countries, and has been
interpreted as a causal association. Results were very similar no
matter whether the standard or the ‘Asian’ categories of BMI were
used. The association reported here for Asia, however, is
somewhat weaker than that observed in high-income countries.
A cohort study of nurses from the United States reported a 20-fold
increased incidence of diabetes for obese women compared to
those with BMI lower than 23 kg/m
2 [20]. In our study, the ORs
comparing obese and normal-weight individuals (i.e., BMI in the
range 17.5–22.4 kg/m2) are in the order of 2.5–3: the difference
with the nurses’ study can hardly be explained by the use of
prevalence data, or different BMI categories. Other studies from
the US, however, reported more modest associations, with 6- to 8-
fold increased incidence [21] or prevalence [22].
An elevated incidence [14] or prevalence [4,12,13,23–27] of
diabetes has been reported to be associated with high BMI in
several previous studies from Asia. The difference in average BMI
between diabetics and controls in these studies ranged between 2
and 4 kg/m
2. In a multicentre study of 2,800 individuals from
China, 6,300 from Japan and 3,300 from India, the age-adjusted
prevalence of diabetes was 2-fold higher in China and 4-fold
higher in Japan and India, across BMI categories 30+ vs. 15 kg/
m
2 [28]. In India, the association was stronger in women than in
Table 2. Odds ratios of diabetes for body mass index, overall and stratified by sex and age.
Body mass index at baseline (Kg/m
2)
,15.0 15.0–17.4 17.5–19.9 20.0–22.4 22.5–24.9 25.0–27.4 27.5–29.9 30.0–32.4 32.5–34.9 35.0–50.0 Slope (SE)
All subjects (n=934,154)
a
N of cases
(prevalence %)
59 (1.4) 530 (1.7) 3309 (2.6) 8795 (3.5) 12743 (4.7) 8279 (5.3) 3934 (6.3) 1464 (7.2) 427 (8.0) 254 (8.8)
OR
a 0.58 0.49 0.57 0.76 1.00 1.21 1.46 1.74 2.05 2.23 0.084
(95% CI) (0.31,0.76) (0.35,0.68) (0.46,0.72) (0.67,0.86) (reference) (1.13,1.29) (1.33,1.61) (1.51,2.00) (1.75,2.40) (1.86,2.67) (0.010)
Men (n=452,785)
N of cases
(prevalence %)
34 (1.7) 289 (1.9) 1936 (3.0) 5306 (4.2) 7257 (5.4) 4519 (6.1) 1896 (7.4) 577 (8.0) 142 (9.0) 67 (9.0)
OR
a 0.65 0.52 0.57 0.75 1.00 1.21 1.45 1.71 2.04 1.93 0.084
(95% CI) (0.35,1.21) (0.35,0.77) (0.44,0.74) (0.65,0.87) (reference) (1.12,1.31) (1.20,1.64) (1.44,2.03) (1.67,2.49) (1.49,2.50) (0.013)
Women (n=481,369)
N of cases
(prevalence %)s
25 (1.2) 241 (1.6) 1373 (2.1) 3489 (2.8) 5486 (3.9) 3760 (4.6) 2038 (5.6) 887 (6.8) 285 (7.6) 187 (8.7)
OR
a 0.47 0.47 0.59 0.79 1.00 1.24 1.50 1.78 2.13 2.42 0.081
(95% CI) (0.31,0.71) (0.36,0.62) (0.48,0.71) (0.71,0.87) (reference) (1.13,1.35) (1.35,1.66) (1.52,2.09) (1.77,2.57) (1.89,3.10) (0.008)
Age,50 (n=334,515)
N of cases
(prevalence %)
6 (0.5) 59 (0.6) 468 (1.0) 1271 (1.3) 1877 (2.0) 1386 (2.6) 696 (3.5) 294 (4.6) 84 (4.9) 41 (4.8)
OR
a 2.55 0.71 0.58 0.69 1.00 1.36 1.90 2.77 3.44 3.95 0.117*
(95% CI) (0.66,9.83) (0.45,1.13) (0.46,0.72) (0.60,0.78) (reference) (1.21,1.53) (1.62,2.24) (2.28,3.36) (2.57,4.61) (2.85,5.47) (0.010)
Age 50–59 (n=292,225)
N of cases
(prevalence %)
11 (1.2) 130 (1.7) 975 (2.7) 2738 (3.6) 4142 (4.6) 2776 (5.3) 1275 (6.1) 502 (7.3) 148 (8.4) 89 (9.6)
OR
a 0.75 0.67 0.64 0.76 1.00 1.21 1.42 1.76 2.29 2.76 0.082*
(95% CI) (0.29,1.95) (0.40,1.12) (0.49,0.84) (0.66,0.89) (reference) (1.12,1.31) (1.27,1.59) (1.49,2.09) (1.87,2.80) (2.21,3.46) (0.013)
Age$60 (n=307,414)
N of cases
(prevalence %)
42 (2.0) 341 (2.6) 1866 (4.2) 4786 (6.1) 6724 (7.7) 4117 (8.1) 1963 (9.2) 668 (9.6) 195 (10.6) 124 (11.2)
OR
a 0.59 0.46 0.55 0.80 1.00 1.15 1.32 1.39 1.68 1.79 0.076*
(95% CI) (0.29,1.19) (0.29,0.71) (0.41,0.72) (0.70,0.91) (reference) (1.07,1.24) (1.19,1.47) (1.17,1.67) (1.40,2.01) (1.48,2.16) (0.011)
aMeta-analysis estimates of cohort-specific OR adjusted for age and sex (when appropriate).
*P-value of difference across strata ,0.001.
OR, odds ratio; CI, confidence interval; SE, standard error.
doi:10.1371/journal.pone.0019930.t002
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and Thailand (2,700 individuals), the adjusted prevalence of
diabetes was compared across BMI categories. In the study from
Bangladesh there was a 4-fold increased prevalence of diabetes
(BMI 30+ vs. ,16 kg/m
2) in urban areas and a 6-fold increased
prevalence in rural areas [29]; in the Thai study, a three-fold
increased incidence was observed for BMI 28+ vs. ,23 kg/m
2
[30]. Our pooled analysis expands on these results and provides a
systematic assessment of the association between body mass and
diabetes prevalence in multiple populations across South and East
Asia. Although our analysis included individuals with very low
BMI (less than 17.5, and even less than 15 kg/m
2), the number of
cases of diabetes in these groups was relatively small, thus
producing imprecise results.
The association between BMI and diabetes prevalence did not
vary between men and women, but was stronger among younger
than among older individuals. There are several possible
explanations for this pattern, which has not been previously
reported in large studies from Asia. First, genetic factors could play
a more important role in those with earlier than later onset of
diabetes, and the stronger association in younger adults could be
due, in part, to joint effects of high BMI and such genetic factors.
Second, the stronger association in younger adults may be due to a
shorter latency of the effect of substantial weight gain, which is
more likely to have occurred in those of younger age. A
prospective cohort study in Japan also found that the effect of
obesity on the risk of incident diabetes was greater for middle-aged
than for older adults [31]. Analyses from a prospective study from
Germany suggest that self-reported weight gain in early adulthood
is related to a higher risk and an earlier onset of type 2 diabetes
than is weight gain later [32]. Third, the interaction could be due
to other factors that are associated with age, such as physical
activity and dietary habits. Finally, it is possible that weight loss
might be more substantial in older patients due to a relatively
longer disease course and, as a result, the prevalent bias might be
more substantial in older patients than younger patients,
attenuating the positive association between BMI and diabetes
prevalence. It should be noticed that this form of bias would affect
more strongly the older age group, but would operate across the
whole study population.
Although generally present in all subgroups of our study
populations, the positive association between BMI and prevalence
of diabetes differed in the countries where the cohorts were
conducted. The association between low BMI and low diabetes
prevalence was strongest in India and Bangladesh, intermediate in
China, Taiwan, Korea, and Singapore, and weakest in Japan. This
pattern was present in both sexes and in all age groups.
Furthermore, the markedly lower diabetes prevalence among lean
subjects was more evident in both Mumbai (an urban cohort) and
Bangladesh (a rural cohort) than in other cohorts. In addition to a
possible contribution of ethnic-specific genetic factors, it is
plausible that low BMI may be a stronger indicator of low caloric
diet throughout life – and, in particular, in early life – in lower-
than in higher-income countries. It has been suggested that a high
intake of white rice can disrupt glucose metabolism [33-34]. An
explanation of the difference observed in the association between
BMI and diabetes in Japan compared to the other countries may
be a better clinical management of overweight and obese
individuals: .because of wide dissemination of general health
checkup in Japan in the past decades, it is possible that a sizable
proportion of the Japanese subjects with history of diabetes have
already reduced their weight at the time of entry into the cohort.
The pattern of results by tobacco smoking may be explained by
an interaction between BMI and this habit in causing diabetes,
possibly through the metabolic, inflammatory, and atherosclerotic
consequences of tobacco [9]. In fact, current smokers had a lower
BMI than former smokers and never smokers (median BMI levels
were 22.3, 22.6 and 23.0 Kg/m
2, respectively [p-value of
difference,0.001]).
Our study provides further evidence that variation in the
occurrence of diabetes in Asia and between Asia and other regions
of the world cannot be fully explained by differences in body mass
distribution among populations. Other anthropometric character-
istics may play a role. Body fat distribution and, in particular,
abdominal obesity, independent of body mass has been shown, in
studies from Asia and other regions, to modify glucose metabolism
and diabetes [27,35–38]. Furthermore, Asian populations have
been shown to exhibit a higher prevalence of abdominal obesity
after adjusting for body mass [39–42]. Finally, there is evidence
that waist circumference and other measures of abdominal obesity
play a bigger role than BMI in determining diabetes risk in Asians
as compared to populations of European descent [5,43–44], but
large-scale studies of unselected populations are needed to fully
understand the shape of the dose-risk relation with different
measures of adiposity. We have no information on this
anthropometric characteristic.
It is plausible that other factors related to country of residence –
either genetic or environmental (lifestyle factors and living
Figure 1. Sex- and age-adjusted prevalence of diabetes by geographic region.
doi:10.1371/journal.pone.0019930.g001
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modify the effect of established risk factors. There is some evidence
that the role of reduced insulin secretion and reduced insulin
sensitivity in determining diabetes risk may differ among
populations. In particular, Indians seem to be more insulin-
resistant than other populations [45]. Variation in intra-abdominal
fat deposition and muscle mass could explain differences in the
prevalence of diabetes and in the association between BMI and
diabetes prevalence across Asian populations. An additional
anthropometric characteristic that might modify the BMI-diabetes
relation is low birth weight, an indicator of intrauterine (and
probably infant) malnutrition. Low birth weight has been
associated with glucose metabolism and risk of diabetes in studies
in India [46–47], and the prevalence of low birth weight is higher
in South Asia than in other regions of the continent [48]. The
highest prevalence of diabetes in our study population was
reported in Japan; there is some evidence that insulin deficiency
rather than insulin resistance is an important factor in determining
diabetes in Japanese individuals [49].
A limitation of our study is the use of self-reported diabetes
status, which may have resulted in misclassification, leading to an
underestimation of the association between BMI and diabetes
Figure 2. A. OR of diabetes for BMI category in men, stratified by geographic region. B. OR of diabetes for BMI category in women,
stratified by geographic region.
doi:10.1371/journal.pone.0019930.g002
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PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e19930prevalence, especially in low-income countries. However, available
data on other indicators of diabetes in some of the cohorts supports
the overall validity of these self-reported data. In this Asian
population, glycosuria was measured in 11,122 (95%) members of
the Bangladesh cohort, including 231 (95%) self-reported cases of
diabetes: although diabetes treatment can influence this marker,
more than 99% of non-cases tested negative for glycosuria and
62% of the cases tested positive. The result is comparable with that
from high-income countries like Japan, where the sensitivity and
specificity of the questionnaire for diabetic hyperglycaemia were
46% and 98%, respectively [14]. Furthermore, the age-adjusted
prevalence in our study populations is consistent with results of
other surveys conducted in most of the countries included in our
study (see [5,43] for reviews); one exception is the cohort from
Mumbai, India, in which the prevalence of self-reported diabetes
was lower than that reported from other surveys of urban
populations from that country [5,26,50–51]. The use of self-
reported information prevented us from distinguishing between
type 1 and type 2 diabetes. Lack of information on BMI before
diagnosis of diabetes is an additional limitation, since weight loss
after the diagnosis (mainly for type 1, but also for type 2) would
result in an underestimate of the role of BMI in determining the
risk of the disease. However, prevalence of type 1 diabetes is
substantially lower than type 2 diabetes in this region [3], and the
inability to distinguish between types of diabetes almost certainly
does not substantially affect the interpretation of the results. The
reversed linear trend for the two lowest BMI groups (,15.0 and
15–17.4) in age,50 group is probably an effect of the presence of
type 1 diabetes. Data from repeated measurements of BMI taken
after the baseline in five of the cohorts show that BMI measured at
baseline probably underestimated true BMI at the time of
diagnosis of diabetes, thus reducing the measured strength of the
association between body mass and prevalence of diabetes. The
cross-sectional design of our study prevented us from studying the
association between body mass and incidence of diabetes.
Our study provides a precise estimate of the shape and the
strength of the association, in Asian populations, between body
mass, as measured by BMI, and prevalence of diabetes, and
identifies different patterns of risk depending on age, country, and
other risk factors for diabetes.
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